Business / Corporate Sep 6, 2021
Daiichi Sankyo positions its COVID-19 vaccine as a booster in Japan
Daiichi Sankyo is aiming for full regulatory approval by the second half of next year.
Daiichi Sankyo is aiming for full regulatory approval by the second half of next year.
The nation's otherwise highly regarded medical system seems unable to adapt quickly to emergencies, or reform to meet such needs.
Among athletes and stakeholders of the Olympics, the virus positivity rate has been only 0.02% with over 400,000 tests conducted so far, organizers said on Sunday.
Analysis has shown positive remarks on Twitter about the Olympics have risen significantly since the opening ceremony on June 23.
The U.S. Food and Drug Administration’s June approval of Aduhelm caused resignations among a panel of independent experts who said the therapy was ineffective.
Over the past decade, Fujifilm parlayed its expertise in film and chemicals to move into medical diagnostics, pharmaceutical manufacturing and supplying materials to chipmakers.
The bank's chief executive officer, David Solomon, has been vocal in opposing work from home, calling it an "aberration.”
The firm edged out bra specialist Wacoal Holdings Corp. last year to become the top seller of women’s intimate wear in Japan.
Nippon Paper Industries Co. aims to create supercapacitors that could store and release energy with vastly improved performance.
While Japan has fared better during the pandemic compared with its Western peers, executives fear that the pace of inoculations will have an impact on potential recovery.